Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

Pembrolizumab

pembrolizumab
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Keytruda POWDER FOR INJECTION, INTRAVENOUS 50 mg      
Comments:

Keytruda medication guide

Defer to outpatient setting.

 

For Updated Formulary Preferred Products (Inpatient and Outpatient): Preferred Products for Select Agents 

Reviewed: December 16, 2014 (Keytruda)

Last updated: Apr. 11, 2024
  • Chemotherapy:






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved